AAAAI 2017

Oral penicillins are associated with less frequent anaphylaxis reactions than parenterally-administered penicillins, but rates are low for both routes, according to new research.

Quality of life and other patient-reported outcomes significantly improved in patients receiving low- and mid-dose fluticasone propionate (Fp) and fluticasone propionate/salmeterol (FS) via a novel multidose dry powder inhaler (MDPI) versus placebo

Reslizumab appears to improve clinical asthma exacerbation rates among patients with Aspirin Exacerbated Respiratory Disease (AERD)

Study data from a randomized, double-blind, placebo-controlled trial of prasugrel for the treatment of AERD presented at the 2017 AAAAI Annual Meeting.